相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality
Jordi Ramon et al.
DIABETES CARE (2022)
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review
Huimin Zou et al.
HEPATOLOGY INTERNATIONAL (2022)
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
Vincent Mallet et al.
JOURNAL OF HEPATOLOGY (2022)
Impact of Metabolic Syndrome on Severity of COVID-19 Illness
Shannon Wu et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2022)
Cross-sectional and longitudinal associations of apolipoprotein A1 and B with glycosylated hemoglobin in Chinese adults
Hongli Dong et al.
SCIENTIFIC REPORTS (2022)
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
Carmine Stolfi et al.
BIOMEDICINES (2022)
COVID-19 Risk Appears to Vary Across Different Alcoholic Beverages
Xi-jian Dai et al.
FRONTIERS IN NUTRITION (2022)
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease br
Da Hea Seo et al.
DIABETES & METABOLISM JOURNAL (2022)
Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis
Yi Luo et al.
JHEP REPORTS (2022)
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection
Zobair M. Younossi et al.
HEPATOLOGY COMMUNICATIONS (2022)
Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: an individual participant data meta-analysis
Ingrid Jullian-Desayes et al.
SLEEP MEDICINE (2021)
Impaired intestinal barrier function in type 2 diabetic patients measured by serum LPS, Zonulin, and IFABP
Jie-Hao Yuan et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
The role of the plasma glycosylated hemoglobin A1c/Apolipoprotein A-l ratio in predicting cardiovascular outcomes in acute coronary syndrome
Feier Song et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Haptoglobin as a Biomarker
S. N. Naryzny et al.
BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY (2021)
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
Zobair M. Younossi et al.
GASTROENTEROLOGY (2021)
Plasma Apolipoproteins A1/B and OxLDL Levels in Patients with Covid-19 As Possible Markers of the Disease
V. V. Pushkarev et al.
CYTOLOGY AND GENETICS (2021)
Thromboinflammation in COVID-19: Can α2-macroglobulin help to control the fire?
Rainer Seitz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Naked Mole-Rat, a Rodent with an Apolipoprotein A-I Dimer
Don L. Puppione et al.
LIPIDS (2021)
Blockade of High-Fat Diet Proteomic Phenotypes Using Exercise as Prevention or Treatment
Sergio F. Martinez-Huenchullan et al.
MOLECULAR & CELLULAR PROTEOMICS (2021)
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Altered high-density lipoprotein composition and functions during severe COVID-19
Floran Begue et al.
SCIENTIFIC REPORTS (2021)
Retail Alcohol and Tobacco Sales During COVID-19
Brian P. Lee et al.
ANNALS OF INTERNAL MEDICINE (2021)
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19
Sema Yagci et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Sven M. Francque et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection
James R. Hilser et al.
JOURNAL OF LIPID RESEARCH (2021)
The MC4R p.Ile269Asn mutation confers a high risk for type 2 diabetes in the Mexican population via obesity dependent and independent effects
Miguel Vazquez-Moreno et al.
SCIENTIFIC REPORTS (2021)
Prognostic value of apolipoproteins in COVID-19 patients: A systematic review and meta-analysis
Juan R. Ulloque-Badaracco et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)
Mechanism-Based Biomarker Prediction for Low-Grade Inflammation in Liver and Adipose Tissue
Jolanda H. M. van Bilsen et al.
FRONTIERS IN PHYSIOLOGY (2021)
Alpha-2-Macroglobulin in Inflammation, Immunity and Infections
Jennifer Vandooren et al.
FRONTIERS IN IMMUNOLOGY (2021)
Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank
Ryan J. Scalsky et al.
PLOS ONE (2021)
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes
Thierry Poynard et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests
Carmit Netanel et al.
AMERICAN JOURNAL OF SURGERY (2021)
High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion
Philipp E. Geyer et al.
EMBO MOLECULAR MEDICINE (2021)
Enterically derived high-density lipoprotein restrains liver injury through the portal vein
Yong-Hyun Han et al.
SCIENCE (2021)
Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States
Wataru Ando et al.
SCIENTIFIC REPORTS (2021)
Remission of Diabetes Following Bariatric Surgery: Plasma Proteomic Profiles
Maria Insenser et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Systemic Inflammation and Microbial Translocation Are Characteristic Features of SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children
Nathella Pavan Kumar et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Impact of COVID-19 in Liver Disease Progression
Miguel Angel Martinez et al.
HEPATOLOGY COMMUNICATIONS (2021)
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
Fernando Bril et al.
DIABETES CARE (2020)
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes
Thierry Poynard et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2020)
HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure
Markus Trieb et al.
JOURNAL OF HEPATOLOGY (2020)
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
Causal Association of Haptoglobin With Obesity in Mexican Children: A Mendelian Randomization Study
Miguel Vazquez-Moreno et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Practical recommendations for the management of diabetes in patients with COVID-19
Stefan R. Bornstein et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
Donata von Reibnitz et al.
FRONTIERS IN ONCOLOGY (2020)
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
Stephen A. Harrison et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
Sumra Nazir et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
A wealth of genotype-specific proteoforms fine-tunes hemoglobin scavenging by haptoglobin
Sem Tamara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
A. Anisonyan et al.
TERAPEVTICHESKII ARKHIV (2020)
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19
Thierry Poynard et al.
PLOS ONE (2020)
DIPPER, a spatiotemporal proteomics atlas of human intervertebral discs for exploring ageing and degeneration dynamics
Vivian Tam et al.
ELIFE (2020)
Association of the genetic variant rs2000999 with haptoglobin and diabetic macrovascular diseases in Chinese patients with type 2 diabetes
Shiyun Wang et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2019)
Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study
Richard N. Appleby et al.
PLOS ONE (2019)
Effects of Caloric Restriction with Protein Supplementation on Plasma Protein Profiles in Middle-Aged Women with Metabolic Syndrome-A Preliminary Open Study
Chia-Yu Chang et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Molecular form and concentration of serum α2-macroglobulin in diabetes
Sonomi Yoshino et al.
SCIENTIFIC REPORTS (2019)
Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis
Rohit Loomba et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Type 2 diabetes-related proteins derived from an in vitro model of inflamed fat tissue
Jean Paul ten Klooster et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Eduardo Vilar-Gomez et al.
JOURNAL OF HEPATOLOGY (2018)
Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
Laurent Genser et al.
JOURNAL OF PATHOLOGY (2018)
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
Mona Munteanu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers
Yoshihiro Kamada et al.
HEPATOLOGY (2015)
The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters
Li Chunming et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2015)
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity
Thierry Poynard et al.
BMJ OPEN (2015)
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331288 participants
Goodarz Danaei et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Simple biochemical parameters and a novel score correlate with absence of fibrosis in patients with nonalcoholic fatty liver disease
Akash Shukla et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2015)
Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia
H. Perazzo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease
Pierre Bedossa
HEPATOLOGY (2014)
Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants
Daniel Seung Kim et al.
NUTRITION & METABOLISM (2014)
Alpha-2-macroglobulin: A physiological guardian
Ahmed A. Rehman et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease
Tim Vanuytsel et al.
TISSUE BARRIERS (2013)
Screening for liver fibrosis by using FibroScan® and FibroTest in patients with diabetes
Victor de Ledinghen et al.
DIGESTIVE AND LIVER DISEASE (2012)
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
Pierre Bedossa et al.
HEPATOLOGY (2012)
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
Thierry Poynard et al.
BMC GASTROENTEROLOGY (2011)
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme et al.
ANNALS OF MEDICINE (2009)
Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes
Sophie Jacqueminet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients
Annunziata Lapolla et al.
JOURNAL OF MASS SPECTROMETRY (2008)
Reference distributions for apolipoproteins Al and B and the apolipoprotein B/Al ratios: A practical and clinically relevant approach in a large cohort
Robert F. Ritchie et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Haptoglobin release by human adipose tissue in primary culture
JN Fain et al.
JOURNAL OF LIPID RESEARCH (2004)
Reference distributions for alpha(2)-macroglobulin: A comparison of a large cohort to the world's literature
RF Ritchie et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2004)
Relationship between alpha-2-macroglobulin, anthropometric parameters and lipid profiles in Thai overweight and obese in Bangkok
R Tungtrongchitr et al.
NUTRITION RESEARCH (2003)
Nephrotic proteinuria has no net effect on total body protein synthesis:: Measurements with 13C valine
MGM de Sain-van der Velden et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)